High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 9, 2015, Pages 1650-1655.e2

  Aziz, Imran ^a   Mumtaz, Saqib ^b   Bholah, Hassan ^b   Chowdhury, Fahmid U ^b   Sanders, David S ^a   Ford, Alexander C ^b,c  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Bile Acid Reabsorption; HADS; PHQ 12; Synthesis

Indexed keywords

TAUROSELCHOLIC ACID SE 75; BILE ACID;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IDIOPATHIC BILE ACID DIARRHEA; IDIOPATHIC DISEASE; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PATIENT HEALTH QUESTIONNAIRE; PHYSICAL ACTIVITY; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; ROME III CRITERIA; SHORT FORM 36; SOMATIZATION; UNITED KINGDOM; WELLBEING; COMPLICATION; GREAT BRITAIN; METABOLISM; MIDDLE AGED;

ADULT; BILE ACIDS AND SALTS; DIARRHEA; FEMALE; GREAT BRITAIN; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

EID: 84939567588     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.03.002     Document Type: Article

References (36)

1. Spiller R., Aziz Q., Creed F., et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007, 56:1770-1798.
2. Manning A.P., Thompson W.G., Heaton K.W., et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978, 2:653-654.
3. Drossman D.A., Thompson W.G., Talley N.J., et al. Identification of subgroups of functional bowel disorders. Gastroenterol Int 1990, 3:159-172.
4. Thompson W.G., Longstreth G.F., Drossman D.A., et al. Functional bowel disorders and functional abdominal pain. Gut 1999, 45(Suppl 2):II43-II47.
5. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
6. Ford A.C., Bercik P., Morgan D.G., et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013, 145:1262-1270.e1.
7. Ford A.C., Chey W.D., Talley N.J., et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009, 169:651-658.
8. Leeds J.S., Hopper A.D., Sidhu R., et al. Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol 2010, 8:433-438.
9. Halpin S.J., Ford A.C. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012, 107:1474-1482.
10. Ford A.C., Spiegel B.M., Talley N.J., et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009, 7:1279-1286.
11. Walters J.R. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. Expert Rev Gastroenterol Hepatol 2010, 4:561-567.
12. Bajor A., Kilander A., Fae A., et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur J Gastroenterol Hepatol 2006, 18:397-403.
13. Walters J.R., Tasleem A.M., Omer O.S., et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 2009, 7:1189-1194.
14. Merrick M.V., Eastwood M.A., Ford M.J. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J (Clin Res Ed) 1985, 290:665-668.
15. Sciarretta G., Vicini G., Fagioli G., et al. Use of 23-selena-25-homocholyltaurine to detect bile acid malabsorption in patients with ileal dysfunction or diarrhea. Gastroenterology 1986, 91:1-9.
16. Vijayvargiya P., Camilleri M., Shin A., et al. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol 2013, 11:1232-1239.
17. Bajor A., Törnblom H., Rudling M., et al. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut 2015, 64:84-92.
18. Pattni S.S., Brydon W.G., Dew T., et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther 2013, 38:967-976.
19. Duboc H., Rainteau D., Rajca S., et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012, 24:513-520. e246-e247.
20. Shin A., Camilleri M., Vijayvargiya P., et al. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013, 11:1270-1275.e1.
21. Covington J.A., Westenbrink E.W., Ouaret N., et al. Application of a novel tool for diagnosing bile acid diarrhoea. Sensors (Basel) 2013, 13:11899-11912.
22. Walters J.R. Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol 2014, 11:426-434.
23. Wedlake L., A'Hern R., Russell D., et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009, 30:707-717.
24. Ersryd A., Posserud I., Abrahamsson H., et al. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment Pharmacol Ther 2007, 26:953-961.
25. Shivaji U.N., Ford A.C. Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic. Frontline Gastroenterol 2014, 5:266-271.
26. Engsbro A.L., Simren M., Bytzer P. Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification. Aliment Pharmacol Ther 2012, 35:350-359.
27. Wong B.S., Camilleri M., Carlson P., et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2012, 10:1009-1015.e3.
28. Spiegel B.M., Farid M., Esrailian E., et al. Is irritable bowel syndrome a diagnosis of exclusion? A survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010, 105:848-858.
29. Richey R., Howdle P., Shaw E., et al. Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance. BMJ 2009, 338:b1684.
30. Evans K.E., Malloy A.R., Gorard D.A. Changing patterns of coeliac serology requests. Aliment Pharmacol Ther 2009, 29:1137-1142.
31. Kurien M., Chaudhary S., McConnell J.R., et al. Letter: bile acid malabsorption - what is the prevalence in patients with chronic diarrhoea?. Aliment Pharmacol Ther 2014, 40:215.
32. Shivaji U.N., Chowdhury F.U., Ford A.C. Letter: bile acid diarrhoea is not a rare cause of diarrhoea in secondary care. Aliment Pharmacol Ther 2014, 40:216.
33. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
34. Spiller R.C., Humes D.J., Campbell E., et al. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment Pharmacol Ther 2010, 32:811-820.
35. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002, 64:258-266.
36. Ware J.E., Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998, 51:903-912.